BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32081855)

  • 1. Impaired motor skill learning and altered seizure susceptibility in mice with loss or gain of function of the Kcnt1 gene encoding Slack (K
    Quraishi IH; Mercier MR; McClure H; Couture RL; Schwartz ML; Lukowski R; Ruth P; Kaczmarek LK
    Sci Rep; 2020 Feb; 10(1):3213. PubMed ID: 32081855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico model reveals the key role of GABA in KCNT1-epilepsy in infancy with migrating focal seizures.
    Kuchenbuch M; Nabbout R; Yochum M; Sauleau P; Modolo J; Wendling F; Benquet P
    Epilepsia; 2021 Mar; 62(3):683-697. PubMed ID: 33617692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K
    Gertler TS; Cherian S; DeKeyser JM; Kearney JA; George AL
    Neurobiol Dis; 2022 Jun; 168():105713. PubMed ID: 35346832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KCNT1 epilepsy with migrating focal seizures shows a temporal sequence with poor outcome, high mortality and SUDEP.
    Kuchenbuch M; Barcia G; Chemaly N; Carme E; Roubertie A; Gibaud M; Van Bogaert P; de Saint Martin A; Hirsch E; Dubois F; Sarret C; Nguyen The Tich S; Laroche C; des Portes V; Billette de Villemeur T; Barthez MA; Auvin S; Bahi-Buisson N; Desguerre I; Kaminska A; Benquet P; Nabbout R
    Brain; 2019 Oct; 142(10):2996-3008. PubMed ID: 31532509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis and EEG markers of KCNT1 epilepsy of infancy with migrating focal seizures.
    Kuchenbuch M; Benquet P; Kaminska A; Roubertie A; Carme E; de Saint Martin A; Hirsch E; Dubois F; Laroche C; Barcia G; Chemaly N; Milh M; Villeneuve N; Sauleau P; Modolo J; Wendling F; Nabbout R
    Epilepsia; 2019 Jan; 60(1):20-32. PubMed ID: 30525185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KCNT1-positive epilepsy of infancy with migrating focal seizures successfully treated with nonnarcotic antitussive drugs after treatment failure with quinidine: A case report.
    Takase C; Shirai K; Matsumura Y; Watanabe T; Watanabe A; Hirasawa-Inoue A; Mizuguchi T; Matsumoto N; Sugai K; Hayashi M
    Brain Dev; 2020 Sep; 42(8):607-611. PubMed ID: 32505479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum.
    Bonardi CM; Heyne HO; Fiannacca M; Fitzgerald MP; Gardella E; Gunning B; Olofsson K; Lesca G; Verbeek N; Stamberger H; Striano P; Zara F; Mancardi MM; Nava C; Syrbe S; Buono S; Baulac S; Coppola A; Weckhuysen S; Schoonjans AS; Ceulemans B; Sarret C; Baumgartner T; Muhle H; Portes VD; Toulouse J; Nougues MC; Rossi M; Demarquay G; Ville D; Hirsch E; Maurey H; Willems M; de Bellescize J; Altuzarra CD; Villeneuve N; Bartolomei F; Picard F; Hornemann F; Koolen DA; Kroes HY; Reale C; Fenger CD; Tan WH; Dibbens L; Bearden DR; Møller RS; Rubboli G
    Brain; 2021 Dec; 144(12):3635-3650. PubMed ID: 34114611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-causing Slack potassium channel mutations produce opposite effects on excitability of excitatory and inhibitory neurons.
    Wu J; Quraishi IH; Zhang Y; Bromwich M; Kaczmarek LK
    Cell Rep; 2024 Mar; 43(3):113904. PubMed ID: 38457342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Epilepsy-Associated KCNT1 Mutation Enhances Excitability of Human iPSC-Derived Neurons by Increasing Slack K
    Quraishi IH; Stern S; Mangan KP; Zhang Y; Ali SR; Mercier MR; Marchetto MC; McLachlan MJ; Jones EM; Gage FH; Kaczmarek LK
    J Neurosci; 2019 Sep; 39(37):7438-7449. PubMed ID: 31350261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy.
    Dilena R; DiFrancesco JC; Soldovieri MV; Giacobbe A; Ambrosino P; Mosca I; Galli MA; Guez S; Fumagalli M; Miceli F; Cattaneo D; Darra F; Gennaro E; Zara F; Striano P; Castellotti B; Gellera C; Varesio C; Veggiotti P; Taglialatela M
    Neurotherapeutics; 2018 Oct; 15(4):1112-1126. PubMed ID: 30112700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Phe932Ile mutation in KCNT1 channels associated with severe epilepsy, delayed myelination and leukoencephalopathy produces a loss-of-function channel phenotype.
    Evely KM; Pryce KD; Bhattacharjee A
    Neuroscience; 2017 May; 351():65-70. PubMed ID: 28366665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of a novel series of 1,2,4-oxadiazole inhibitors of SLACK potassium channels: Identification of in vitro tool VU0935685.
    Qunies AM; Spitznagel BD; Du Y; David Weaver C; Emmitte KA
    Bioorg Med Chem; 2023 Nov; 95():117487. PubMed ID: 37812884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule inhibitors of Slack potassium channels as potential therapeutics for childhood epilepsies.
    M Qunies A; A Emmitte K
    Pharm Pat Anal; 2022 Mar; 11(2):45-56. PubMed ID: 35369761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Patients With KCNT1-Related Epilepsy Responding to Phenobarbital and Potassium Bromide.
    Datta AN; Michoulas A; Guella I; ; Demos M
    J Child Neurol; 2019 Oct; 34(12):728-734. PubMed ID: 31208268
    [No Abstract]   [Full Text] [Related]  

  • 15. [Early infantile epileptic encephalopathy type 14: three cases of epilepsy in infancy with migrating focal seizures due to KCNT1 mutations].
    Kholin AA; Zavadenko NN; Fedonyuk ID; Antonets AV; Mukhin KY; Malov AG; Vshivkov MI; Anisimov GV; Il'ina ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(7. Vyp. 2):74-82. PubMed ID: 31532594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced GABAergic Neuron Excitability, Altered Synaptic Connectivity, and Seizures in a KCNT1 Gain-of-Function Mouse Model of Childhood Epilepsy.
    Shore AN; Colombo S; Tobin WF; Petri S; Cullen ER; Dominguez S; Bostick CD; Beaumont MA; Williams D; Khodagholy D; Yang M; Lutz CM; Peng Y; Gelinas JN; Goldstein DB; Boland MJ; Frankel WN; Weston MC
    Cell Rep; 2020 Oct; 33(4):108303. PubMed ID: 33113364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting K
    Cole BA; Clapcote SJ; Muench SP; Lippiat JD
    Trends Pharmacol Sci; 2021 Aug; 42(8):700-713. PubMed ID: 34074526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KCNT1-related epilepsy: An international multicenter cohort of 27 pediatric cases.
    Borlot F; Abushama A; Morrison-Levy N; Jain P; Puthenveettil Vinayan K; Abukhalid M; Aldhalaan HM; Almuzaini HS; Gulati S; Hershkovitz T; Konanki R; Lingappa L; Luat AF; Shafi S; Tabarki B; Thomas M; Yoganathan S; Alfadhel M; Arya R; Donner EJ; Ehaideb SN; Gowda VK; Jain V; Madaan P; Myers KA; Otsubo H; Panda P; Sahu JK; Sampaio LPB; Sharma S; Simard-Tremblay E; Zak M; Whitney R
    Epilepsia; 2020 Apr; 61(4):679-692. PubMed ID: 32167590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A challenging case of epilepsy in infancy with migrating focal seizures due to a de novo KCNT1 missense variant (c.1438G>A, p.Asp480Asn).
    León-Ruiz M; Alonso-Singer P; Merino-Andreu M; Castañeda-Cabrero C
    Seizure; 2024 Apr; 117():202-205. PubMed ID: 38461786
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and molecular characterization of
    McTague A; Nair U; Malhotra S; Meyer E; Trump N; Gazina EV; Papandreou A; Ngoh A; Ackermann S; Ambegaonkar G; Appleton R; Desurkar A; Eltze C; Kneen R; Kumar AV; Lascelles K; Montgomery T; Ramesh V; Samanta R; Scott RH; Tan J; Whitehouse W; Poduri A; Scheffer IE; Chong WKK; Cross JH; Topf M; Petrou S; Kurian MA
    Neurology; 2018 Jan; 90(1):e55-e66. PubMed ID: 29196579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.